These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 374091)

  • 21. [Factors determining prolonged chimerism of lymphoid tissue in mice treated with cyclophosphamide].
    Novikov TK; Kondrat'eva IA; Fontalin LN; Pevnitskiĭ LA
    Biull Eksp Biol Med; 1976 Feb; 81(2):194-7. PubMed ID: 945088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The nature of immunodeficiency induced by injections of lectins and cyclophosphamide].
    Kondrat'eva TK; Mikheeva NV; Fontalin LN
    Biull Eksp Biol Med; 1988 Aug; 106(8):195-8. PubMed ID: 3261998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocyte function in experimental African trypanosomiasis. II. Splenic suppressor cell activity.
    Wellhausen SR; Mansfield JM
    J Immunol; 1979 Mar; 122(3):818-24. PubMed ID: 376707
    [No Abstract]   [Full Text] [Related]  

  • 24. Suppression of the immune response to altered self induced by immunogenic and nonimmunogenic altered self structures.
    Ramos T; Möller E; Möller G
    Eur J Immunol; 1980 Feb; 10(2):100-4. PubMed ID: 6989616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunosuppression of normal lymphoid cells by serum from mice undergoing chronic graft-vs-host disease.
    McMaster R; Levy JG
    J Immunol; 1975 Nov; 115(5):1400-3. PubMed ID: 240891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aggregated IgG-induced suppression of in vitro antibody responses: definition of the cellular target(s).
    Nicholson JK; McDougal JS
    J Immunol; 1981 Jun; 126(6):2382-9. PubMed ID: 6453164
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro responses of CBA/N mice: spleen cells of mice with an X-linked defect that precludes immune responses to several thymus-independent antigens can respond to TNP-lipopolysaccharide.
    Mosier DE; Scher I; Paul WE
    J Immunol; 1976 Oct; 117(4):1363-9. PubMed ID: 789772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune suppression in vivo with antigen-modified syngeneic cells. III. Distinctions between T cell tolerance and T cell mediated suppression.
    Sherr DH; Heghinian KM; Benacerraf B; Dorf ME
    J Immunol; 1979 Dec; 123(6):2682-8. PubMed ID: 91641
    [No Abstract]   [Full Text] [Related]  

  • 29. Nature of tolerance induction to peripheral (extrathymic) islet allografts.
    Coulombe M; Lafferty KJ; Gill RG
    Transplant Proc; 1994 Apr; 26(2):720-1. PubMed ID: 8171624
    [No Abstract]   [Full Text] [Related]  

  • 30. The influence of cigarette tobacco smoke products on the immune response. The cellular basis of immunosuppression by a water-soluble condensate of tobacco smoke.
    Jacob CV; Stelzer GT; Wallace JH
    Immunology; 1980 Aug; 40(4):621-7. PubMed ID: 7000690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mouse mutant "motheaten". I. Development of lymphocyte populations.
    Sidman CL; Shultz LD; Unanue ER
    J Immunol; 1978 Dec; 121(6):2392-8. PubMed ID: 363946
    [No Abstract]   [Full Text] [Related]  

  • 32. Immune depression in trypanosome-infected mice. II. Characterization of the spleen cell types involved.
    Roelants GE; Pearson TW; Tyrer HW; Mayor-Withey KS; Lundin LB
    Eur J Immunol; 1979 Mar; 9(3):195-9. PubMed ID: 156119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surface membrane kappa and lambda light chain expression on spleen cells of neonatal and maturing normal and immune-defective CBA/NB mice: the kappa:lambda ratio is constant.
    Kessler S; Kim KJ; Scher I
    J Immunol; 1981 Oct; 127(4):1674-8. PubMed ID: 6792281
    [No Abstract]   [Full Text] [Related]  

  • 34. Cloning of B cells positive or negative for surface IgD. I. Triggering and tolerance in T-independent systems.
    Layton JE; Pike BL; Battye FL; Nossal GJ
    J Immunol; 1979 Aug; 123(2):702-8. PubMed ID: 379215
    [No Abstract]   [Full Text] [Related]  

  • 35. The induction of hapten-specific immunologic tolerance and immunity in B lymphocytes. IV. Induction of TNP-specific unresponsiveness in vitro with serum from tolerant mice.
    Fidler JM
    J Immunol; 1978 Oct; 121(4):1558-65. PubMed ID: 308969
    [No Abstract]   [Full Text] [Related]  

  • 36. B lymphocyte subpopulations separated by velocity sedimentation. II. Characterization of tolerance susceptibility.
    Teale JM; Howard MC; Nossal GJ
    J Immunol; 1978 Dec; 121(6):2561-5. PubMed ID: 363949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Suppression of antibody formation by bone marrow B-lymphocytes in spleen cell cultures from mice of different genotypes].
    Petrov RV; Khaitov RM; Ataullakhanov RI; Sidorovich IG
    Dokl Akad Nauk SSSR; 1977 Apr; 233(4):745-8. PubMed ID: 300675
    [No Abstract]   [Full Text] [Related]  

  • 38. Induction fo B cell tolerance by antigen specific T cell factor.
    Feldman M
    Nat New Biol; 1973 Mar; 242(116):82-4. PubMed ID: 4572534
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibody response of mice following neonatal treatment with a monoclonal anti-receptor antibody. Evidence for B cell tolerance and T suppressor cells specific for different idiotopic determinants.
    Cerny J; Cronkhite R; Heusser C
    Eur J Immunol; 1983 Mar; 13(3):244-8. PubMed ID: 6187584
    [No Abstract]   [Full Text] [Related]  

  • 40. High anti-TNP plaque-forming cell potential of residual mIg+ cells in a T cell population.
    Mond JJ; Mage MG; Rothstein TL; Mosier DE; Herrod H; Asofsky R; Paul WE
    J Immunol; 1980 Oct; 125(4):1526-9. PubMed ID: 6774022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.